Comments
Fortis Healthcare (India) Ltd has acquired 85 per cent stake in Singapore-based diagnostic chain RadLink-Asia Pte Ltd for S$62.9 million (about Rs 250 crore). The acquisition was done through Fortis Healthcare International, a wholly-owned unit of the Indian company.
“The transaction provides Fortis Healthcare a strong foothold in the premium diagnostics and molecular imaging segment in one of South-East Asia's most attractive markets, besides providing a complementary platform to its upcoming specialty hospital on Adam Road in Singapore,” Fortis said in a notification to the stock exchanges.
RadLink operates in four business segments — diagnostic imaging, molecular imaging, cyclotron (radioisotopes manufacturing), and GP clinics.
Across Asia-Pacific
Fortis now has 74 hospitals and 190 diagnostic labs across India and other Asian countries. This includes Quality Healthcare Ltd, a primary care network in Hong Kong with 580 centres; Dental Corporation Pty Ltd — a dental care network in Australia and New Zealand with 174 centres; Fortis Speciality Hospital, an under-construction speciality hospital in Singapore; a stake in 350-bed Lanka Hospitals Corporation, and the largest private pathology laboratory in the UAE.
Further, it recently announced the acquisition of a 65 per cent stake in Hoan My Medical Corporation, one of Vietnam's largest private healthcare provider groups with over 1,100 beds across six hospitals.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.